Tissue engineering strategies for construction of artificial salivary glands based on decellularized scaffolds of rats.
Dai T., Shi L., Kong H., Zhao L., Wang Y., Cao Y.
Animal Study on Scar, published in Biomaterials (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Biomaterials (2026)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41895021
- DOI
- 10.1016/j.biomaterials.2026.124166
Abstract (original English)
Salivary gland (SG) hypofunction is a debilitating condition with no curative treatments. Tissue engineering based on decellularized scaffolds represents a promising regenerative strategy; however, its application to SGs has been limited by inadequate decellularization techniques and scarce cell sources. Here, we developed a novel perfusion-based decellularization method via the ductal and venous systems to generate rat submandibular gland scaffolds. This approach efficiently removed cellular components while optimally preserving the native three-dimensional architecture, key extracellular matrix (ECM) components, and the integrity of ductal and vascular networks. We then constructed artificial SGs by recellularizing these biomimetic scaffolds through the ductal route with salivary gland cells (SGCs), adipose-derived stromal cells (ADSCs), or SGC-pre-induced ADSCs. In vitro perfusion culture revealed that all cell sources, including transdifferentiated ADSCs, supported the formation of acinar-like structures and expressed the functional marker α-amylase (α-AMY), with peak performance observed at day 5. Upon in vivo transplantation, the tissue-engineered glands maintained partial α-AMY expression for up to 5 days, demonstrating short-term survival and function. However, graft longevity was limited beyond 7 days, primarily due to insufficient vascularization. Our study establishe
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Clinical Applications of Autologous Fat Grafting in Pathological Hand Conditions.
Systematic Review with a reported sample of 7 on Osteoarthritis, Scar, published in J Hand Surg Asian Pac Vol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 7
J Hand Surg Asian Pac Vol - Level AMeta-analysisPubMed
Stem cell therapy in thin endometrium and Asherman's syndrome: a systematic review and meta-analysis.
Meta-analysis with a reported sample of 323 on Scar, published in Eur J Obstet Gynecol Reprod Biol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 323
Eur J Obstet Gynecol Reprod Biol - Level AMeta-analysisEurope PMC
Therapeutic value of mesenchymal stem cell-derived extracellular vesicles in hypertrophic and keloid scars: a systematic review and meta-analysis
Meta-analysis on Chronic Wound, Scar, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
Front Cell Dev Biol - Level AMeta-analysisPubMed
Efficacy and safety of autologous cell-based therapies for atrophic acne scar treatment: an updated systematic review and meta-analysis with in-depth methodological and clinical insights.
Meta-analysis with a reported sample of 500 on Chronic Wound, Scar, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 500
Front Cell Dev Biol - Level ASystematic ReviewEurope PMC
Comparative Efficacy and Safety of Fractional CO<sub>2</sub> Laser and Gold Microneedling Radiofrequency for Atrophic Acne Scars: A Systematic Review
Systematic Review on Chronic Wound, Scar, published in Skin Res Technol (2026) — summary generated from the PubMed abstract.
- 2026
Skin Res Technol - Level AMeta-analysisPubMed
Role of exosome therapy in reconstructive surgery: a review.
Meta-analysis on Chronic Wound, Scar, Immune Modulation, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Med (Lausanne)1 citations